VOOZH about

URL: https://pubmed.ncbi.nlm.nih.gov/15626342/

⇱ The M protein of SARS-CoV: basic structural and immunological properties - PubMed


Clipboard, Search History, and several other advanced features are temporarily unavailable.
Skip to main page content
👁 Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

👁 Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Abstract

We studied structural and immunological properties of the SARS-CoV M (membrane) protein, based on comparative analyses of sequence features, phylogenetic investigation, and experimental results. The M protein is predicted to contain a triple-spanning transmembrane (TM) region, a single N-glycosylation site near its N-terminus that is in the exterior of the virion, and a long C-terminal region in the interior. The M protein harbors a higher substitution rate (0.6% correlated to its size) among viral open reading frames (ORFs) from published data. The four substitutions detected in the M protein, which cause non-synonymous changes, can be classified into three types. One of them results in changes of pI (isoelectric point) and charge, affecting antigenicity. The second changes hydrophobicity of the TM region, and the third one relates to hydrophilicity of the interior structure. Phylogenetic tree building based on the variations of the M protein appears to support the non-human origin of SARS-CoV. To investigate its immunogenicity, we synthesized eight oligopeptides covering 69.2% of the entire ORF and screened them by using ELISA (enzyme-linked immunosorbent assay) with sera from SARS patients. The results confirmed our predictions on antigenic sites.

PubMed Disclaimer

Figures

👁 Fig.1
Fig. 1
The distribution of GC content (I), charge (II), the predicted hydrophobicity and antigenicity (III) and secondary structures (IV) of the M protein.
👁 Fig.2
Fig. 2
The predicted transmembrane domains of the M protein.
👁 Fig. 3
Fig. 3
Predicted signal peptides and cleavage sites of the M protein in six coronaviruses.
👁 Fig. 4
Fig. 4
The predicted transmembrane domains in six coronaviruses.
👁 Fig. 5
Fig. 5
The multiple alignments of amino acid sequences of the M protein in 12 coronaviruses.
👁 Fig. 6
Fig. 6
A phylogenetic tree of the coronaviruses based on the M protein. A: ClustalW, output by Treeview. B: ClustalW, output by Phylodraw. AIBV: avian infectious bronchitis virus: BCoV: bovine coronavirus; CCoV: canine coronavirus; FCoV: feline coronavirus; FIPV: feline infectious peritonitis virus: HCoV-229E: human coronavirus 229E; HCoV-OC43: human coronavirus OC43; MHV: murine hepatitis virus; PEDV: porcine epidemic diarrhea virus; PHEV: porcine hemagglutinating encephalomyelitis virus; PRCoV(PRV): porcine respiratory coronavirus; PTGV: porcine transmissible gastroenteritis virus; RCoV: rat coronavirus; RSCoV: rat sialodacryoadenitis coronavirus; SARS-CoV: the human SARS-associated coronavirus; TCoV (TVC): turkey coronavirus.
👁 Fig. 7
Fig. 7
The immunoassay of oligopeptides in a 96-well plate. The sample distribution listed in Table 3.
👁 Fig. 8
Fig. 8
The average immune reactivity of 8 oligopeptides by ELISA. Four oligopeptides show higher absorbance, suggesting immune reactivity with sera from SARS patients. Synthetic oligopeptides cover all the three predicted subregions of the M protein except for partial TM regions with extremely high hydrophobicity and low predicted antigenicity.
👁 Fig.9
Fig. 9
A diagram of the predicted TM structure in the SARS-CoV M protein.

References

    1. Michael M. Plenum Press; New York, USA: 1986. Coronaviruses; pp. 108–135.
    1. Lapps W. Sequence analysis of the bovine Coronavirus nucleocapsid and matrix protein genes. Virology. 1987;157:47–57. - PMC - PubMed
    1. Fleming J.O. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 1989;168:162–167. - PMC - PubMed
    1. Armstrong J. Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a Coronavirus. Nature. 1984;308:751–752. - PMC - PubMed
    1. Narayanan K. Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J. Virol. 2000;74:8127–8134. - PMC - PubMed
Cite

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.